 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MIRA Pharmaceuticals Shows its Prescription Pill More Palatable and Potent Than Pot MIRA Pharmaceuticals Shows its Prescription Pill More Palatable and Potent Than Pot PR Newswire BALTIMORE, Sept...

MIRA Pharmaceuticals Shows its Prescription Pill More Palatable and Potent Than Pot

MIRA Pharmaceuticals to Participate in 6th Annual Cannabinoid-Derived Drug Development Summit MIRA Pharmaceuticals to Participate in 6th Annual Cannabinoid-Derived Drug Development Summit PR Newswire BALTIMORE, Aug. 31, 2023 BALTIMORE, Aug. 31, 2023 /PRNewswire/ --MIRA Pharmaceuticals, Inc...

MIRA Pharmaceuticals to Participate in 6th Annual Cannabinoid-Derived Drug Development Summit

MIRA Pharmaceuticals to Host Virtual Roadshow Webinar on Monday, September 11, 2023 at 1:00 p.m. Eastern Time MIRA Pharmaceuticals to Host Virtual Roadshow Webinar on Monday, September 11, 2023 at 1:00 p.m. Eastern Time PR Newswire BALTIMORE, Aug. 29, 2023 BALTIMORE, Aug. 29, 2023 /PRNewswire...

MIRA Pharmaceuticals to Host Virtual Roadshow Webinar on Monday, September 11, 2023 at 1:00 p.m. Eastern Time

MIRA Pharmaceuticals to Ring the Nasdaq Opening Bell on Wednesday, August 9, 2023 MIRA Pharmaceuticals to Ring the Nasdaq Opening Bell on Wednesday, August 9, 2023 PR Newswire BALTIMORE, Aug. 9, 2023 BALTIMORE, Aug. 9, 2023 /PRNewswire/ --MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ('MIRA&quot...

MIRA Pharmaceuticals to Ring the Nasdaq Opening Bell on Wednesday, August 9, 2023

PHOENIX, AZ / ACCESSWIRE / August 9, 2023 / The Stock Day Podcast welcomed MIRA Pharmaceuticals, Inc.(Nasdaq:MIRA) ('the Company'), a pre-clinical-stage pharmaceutical development company developing a Novel synthetic THC analog. CEO of the Company, Erez Aminov, joined Stock Day host Kevin...

MIRA Pharmaceuticals, Inc. Discusses Potential of Revolutionary THC Analog Drug, MIRA1a, with The Stock Day Podcast

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company engages in developing its product candidate, MIRA1a, as a synthetic cannabinoid analog for treating anxiety & chronic pain by targeting the cannabinoid type 1 and type 2 (CB1 and CB2) receptors. MIRA Pharmaceuticals was founded by Adam Kaplin on September 3, 2020 and is headquartered in Baltimore, MD.

Watchers	135
52-Wk Low	$3.00
52-Wk High	$7.98

Market Cap	$69.3M
Volume (M)	12,678.00
52-Wk High	$7.98
52-Wk Low	$3.00

MIRA MIRA PHARMACEUTICALS INC

About

Feed

News

Fundamentals